Dr. Brill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9114 Philadelphia Rd
Ste 310
Baltimore, MD 21237Phone+1 410-686-3394
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Surgical Retina and Vitreous, 2021 - 2023
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 2020 - 2021
- Henry Ford Health/Henry Ford HospitalResidency, Ophthalmology, 2017 - 2020
- Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 2016 - 2017
- Pennsylvania State University College of MedicineClass of 2016
- Vanderbilt UniversityBA, 2008 - 2012
Certifications & Licensure
- MD State Medical License 2023 - 2026
- VA State Medical License 2023 - 2026
- OH State Medical License 2021 - 2025
- DC State Medical License 2023 - 2024
- MA State Medical License 2020 - 2022
- MI State Medical License 2016 - 2020
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Scleritis and episcleritis in patients with idiopathic small fiber neuropathy.Atitaya Apivatthakakul, Renee Liu, Marez Megalla, Daniel A Brill, Lucia Sobrin
American Journal of Ophthalmology Case Reports. 2024-12-01 - Real-World Long-Term Outcomes of Intravitreal Faricimab in Previously Treated Chronic Neovascular Age-Related Macular Degeneration.Naveen R Ambati, Adam Leone, Daniel Brill, Robert A Sisk
Retina. 2024-11-11 - Malignancy Risk Associated With the Use of Systemic Immunomodulatory Therapy in the Management of Noninfectious Uveitis.George N Papaliodis, Yinxi Yu, Daniel A Brill, Lucia Sobrin, Brian VanderBeek
American Journal of Ophthalmology. 2024-09-01
Authored Content
- Fluorescein Angiography of Persistent Incomplete Vascularization of the Retina After Bevacizumab Therapy in Retinopathy of PrematurityJuly 2019
- Bartonella neuroretinitis: an optical coherence tomography seriesDecember 2018
Press Mentions
- Diagnosis and Management of Pathologic MyopiaNovember 1st, 2019
- Monetizing Medicine: Private Equity and Competition in Physician Practice MarketsJuly 18th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: